Navigation Links
Results of TRIUMPH-1 Trial of Viveta in Pulmonary Arterial Hypertension to Be Announced Before Market Open on Thursday, November 1, 2007
Date:10/31/2007

ternational callers dialing 1-706-679-8129. A rebroadcast of the teleconference will be available for one week following the teleconference by dialing 1-800-642-1687, with international callers dialing 1-706-645-9291, and using access code 20811764.

This teleconference is also being web cast and can be accessed via United Therapeutics' website at http://ir.unither.com/eventdetail.cfm?eventid=45704.

About United Therapeutics

United Therapeutics is a biotechnology company focused on the development and commercialization of unique products for patients with chronic and life- threatening cardiovascular, cancer and infectious diseases. [uthr-g]

About Lung Rx

Lung Rx is a biotechnology company focused on unmet medical needs in pulmonary medicine and pulmonary delivery of innovative therapeutic products.

Viveta is a trademark of Lung Rx, Inc.

Tracleer is a registered trademark of Actelion Ltd.

Revatio is a registered trademark of Pfizer Inc.


'/>"/>
SOURCE United Therapeutics Corporation
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
2. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
6. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
7. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...4/PRNewswire/--Inadditiontofamily,friendsandhealth...rorstoherThanksgivinggratitudelist. ,, "Theyhea...,"shesaidofMonday,sverdictstotaling$103millioninda...among12,000womennationwidewhohavesuedWyethandPfize...marinandPrempro.Wisneskiandtheothervictimsofhormon...
(Date:11/24/2009)...RNewswire/--Accumetrics,Inc.,aprivately-helddevelo...apidandeasy-to-usediagnosticsystemformeasuringanin....Plavix®andaspirin),announcedtodaythatTimothy...ibbitts,ChiefFinancialOfficerofAccumetrics,willbep...frayHealthCareConferencebeingheldinNewYorkCityonDe...
(Date:11/24/2009)...24/PRNewswire/--PharmaceuticalInstitute,aleadingpr...uticalandbiotechindustry,todayannouncedthelaunchof...spitalMarketplace e-courseisthenewestadditiontothe...prehensiveseriesofe-coursesdesignedtofillthecritic...rcommercialprofessionals. ,, Thenewthreemodule ...
Breaking Medicine Technology:Maryland Woman Thankful for Wyeth Verdicts 2Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Pharmaceutical Institute Launches New Training Resource Focused on the Hospital Marketplace 2Genomatica Produces Pure BDO From Natural Sugars 12413 1Genomatica Produces Pure BDO From Natural Sugars 12413 2Genomatica Produces Pure BDO From Natural Sugars 12413 3Genomatica Produces Pure BDO From Natural Sugars 12413 4China Nepstar Chain Drugstore Appoints Chief Operating Officer 47595 1China Nepstar Chain Drugstore Appoints Chief Operating Officer 47595 2China Nepstar Chain Drugstore Appoints Chief Operating Officer 47595 3Genoptix Announces Participation at the 29th Annual William Blair Growth Stock Conference 47590 1Genoptix Announces Participation at the 29th Annual William Blair Growth Stock Conference 47590 2
... Data from the Phase III ZODIAC study in advanced ...stigational drug vandetanib, were presented today ...) meeting in Orlando. Results show that the study ...ddition of vandetanib to docetaxel resulted in a s...n-free survival (PFS), the length of time a patien...
...emonstrated that Induction Chemotherapy prior to C...reatment failure in comparison to standard ChemoRa...h Head and Neck Cancer Cooperative Group (TTCC) an...ivered prior to standard ChemoRadiotherapy (CRT), ..., compared to upfront CRT alone, significantly pro...
Other Medicine Technology:Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology 2Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology 3Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology 4Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology 5Induction Chemotherapy Followed by ChemoRadiotherapy Increased Time-to-Treatment Failure Compared to ChemoRadiotherapy Alone in Patients With Unresectable Locally Advanced Head & Neck Cancer 2Induction Chemotherapy Followed by ChemoRadiotherapy Increased Time-to-Treatment Failure Compared to ChemoRadiotherapy Alone in Patients With Unresectable Locally Advanced Head & Neck Cancer 3
(Date:11/25/2009)...ss release is available in French . , , Mont... are about to enter the marketplace, thanks to a n...artnership (Univalor) and Cognitive Sensing Inc. (...n Montreal. , Univalor, which commercializes dis...iliated institutions, and CSI have announced the s...
(Date:11/25/2009)...ov. 25, 2009 Physicians at UT Southwestern Medica...esigned to improve breathing in patients with uppe... them from breathing independently. , UT Southw...f only two sites in Texas and one of 25 in the cou...led the NeuRx Diaphragm Pacing System. , The dev...
(Date:11/25/2009)...hemo boosts surgery success for patients with live...Y, Nov. 25 (HealthDay News) -- Adding the drug cet...rs and boost the odds of successful surgery in col... liver lesions, new research suggests. , , Tum... half of patients with colorectal cancer. Most com...
(Date:11/25/2009)... offer waistline-friendly ways to enjoy festive fe... News) -- If you love the five-week holiday smorga...eady stressing about the added pounds you,ll have ...,s possible, say nutrition experts, to enjoy holid...as you do today. , It,s all about devising a s...
(Date:11/25/2009)... PCU College teaches students to use...hods. , Burnaby, BC (Vocu...y and radiation are the standard, effective treatm...urn to alternative medicine to help them cope with...an increased number of cancer patients using acupu...
Breaking Medicine News(10 mins):Health News:Univalor and Cognitive Sensing Inc. to commercialize 4 University of Montreal discoveries 2Health News:New device implanted by surgeons help paralyzed patients breathe easier 2Health News:Cetuximab Helps Treat Colorectal Cancer 2Health News:Holiday Eating Without the Guilt -- or the Pounds 2Health News:Holiday Eating Without the Guilt -- or the Pounds 3Health News:Holistic and Western Medicine Combined Can Fight Cancer 2
... Arrow International,Inc. (Nasdaq: ARRO ) today s...vote today on the WHITE proxy card for its planned...TFX ) and to re-elect the Arrow Board of,Directors...nsummated. The Annual Meeting is on September 20, ...
...13 Microtek Medical,Holdings, Inc. (Nasdaq: MTMD...ination of the waiting period under the Hart-Scott...nded, in connection with Ecolab Inc.,s,pending acq...close during the fourth quarter of 2007. About Mi...
...Robles, founder of,Manifestingtruth.com, has been ...credible new class, "Powerful Miracle Manifestatio...ugh Anna by her Angels and is instilling,a sense o...ted taking your courses and everything that you we...
...2007) -- Smaller-framed women reap significant hea...tions that involve the removal of under 500 grams ...kind study from NewYork-Presbyterian Hospital/Weil...panies, who typically do not reimburse women for t...
...13 Acuo Technologies(R), a,company specializing i...e,for intelligent medical image management, DICOM ...on tools and services announces the appointment of... actively assisting healthcare IT entities transit...
...ly prone to unprotected sex, research shows , ...IV epidemic among gay men can,t be explained by th...port. , More than half the new HIV infections diag... men living in cities may be HIV-positive. , But t...
Other Medicine News:Health News:Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Directors 2Health News:Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Directors 3Health News:Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Directors 4Health News:Microtek Medical Receives Early Termination of Hart-Scott-Rodino Act Waiting Period for Its Proposed Acquisition by Ecolab 2Health News:Microtek Medical Receives Early Termination of Hart-Scott-Rodino Act Waiting Period for Its Proposed Acquisition by Ecolab 3Health News:Spiritual Healer/Psychic-Medium Reaches International Status! 2Health News:Smaller breast reduction surgeries provide health benefits and should be reimbursed 2Health News:Acuo Technologies(R) Names Mike Dolan Vice President of Sales 2Health News:Number of Partners Doesn't Explain Gay HIV Rate 2Health News:Number of Partners Doesn't Explain Gay HIV Rate 3
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
Medicine Products: